Cannell Peter B & Co. Inc. Cuts Stake in Thermo Fisher Scientific Inc. (TMO)

Cannell Peter B & Co. Inc. decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 29,112 shares of the medical research company’s stock after selling 2,455 shares during the quarter. Cannell Peter B & Co. Inc.’s holdings in Thermo Fisher Scientific were worth $5,508,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. SPF Beheer BV boosted its stake in Thermo Fisher Scientific by 6.5% in the 3rd quarter. SPF Beheer BV now owns 460,988 shares of the medical research company’s stock worth $87,288,000 after purchasing an additional 28,002 shares during the period. Cornerstone Investment Partners LLC boosted its stake in Thermo Fisher Scientific by 0.3% in the 3rd quarter. Cornerstone Investment Partners LLC now owns 422,671 shares of the medical research company’s stock worth $79,969,000 after purchasing an additional 1,130 shares during the period. Meiji Yasuda Asset Management Co Ltd. boosted its stake in Thermo Fisher Scientific by 0.8% in the 3rd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 35,630 shares of the medical research company’s stock worth $6,741,000 after purchasing an additional 300 shares during the period. Rothschild Asset Management Inc. boosted its stake in Thermo Fisher Scientific by 14.2% in the 3rd quarter. Rothschild Asset Management Inc. now owns 337,738 shares of the medical research company’s stock worth $63,900,000 after purchasing an additional 41,969 shares during the period. Finally, Pacer Advisors Inc. boosted its stake in Thermo Fisher Scientific by 13.8% in the 3rd quarter. Pacer Advisors Inc. now owns 10,314 shares of the medical research company’s stock worth $1,951,000 after purchasing an additional 1,247 shares during the period. Institutional investors own 86.16% of the company’s stock.

Several research analysts have commented on TMO shares. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research note on Thursday, September 7th. Morgan Stanley restated an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research note on Wednesday, September 6th. Cowen restated an “outperform” rating and issued a $220.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Sunday, September 10th. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Monday, October 30th. Finally, Deutsche Bank set a $226.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, October 26th. One investment analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus price target of $205.21.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) traded up $2.33 on Monday, hitting $187.96. The stock had a trading volume of 2,437,700 shares, compared to its average volume of 1,564,998. The company has a market cap of $75,371.09, a P/E ratio of 20.66, a PEG ratio of 1.72 and a beta of 1.06. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc. has a 12-month low of $139.88 and a 12-month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same quarter last year, the company posted $2.03 EPS. equities research analysts expect that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.19%.

In other news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the completion of the sale, the chief executive officer now owns 252,577 shares in the company, valued at approximately $47,582,981.03. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.49% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Cannell Peter B & Co. Inc. Cuts Stake in Thermo Fisher Scientific Inc. (TMO)” was first posted by Stock Observer and is the sole property of of Stock Observer. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.thestockobserver.com/2017/12/11/cannell-peter-b-co-inc-cuts-stake-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply